Abstract
Objectives
The aim of this study was to assess the feasibility, effectiveness, and safety of a novel moderate conscious sedation protocol of Dexmedetomidine plus Midazolam (MID-DEX MCS) in patients undergoing transcatheter left atrial appendage closure (LAAC).